Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | 1 | 3052155 | IM / LA |
3 days after vaccination a subconjunctival hemorrhage developed in the nose side of the left eye. No pain or other symptoms were noted. The area of blood in the white of the eye grew for 2 days covering the quadrant from 6 to 10 o'clock on a dial. On day 6 after appearance, the blood substantially cleared. The most recent prior subconjunctival hemorrhage occurred in 2014 in the right eye 1 day after cold symptoms appeared.
None.
Hypertension, hypercholesteremia, borderline pre-diabetes, open angle glaucoma
Telmisartan, Pitavastatin, Low-dose aspirin, multi-vitamin, Timolol+Dorzolamide eyedrops
None.
None.
Sudden unilateral sensorineural hearing loss one day after Encepur vaccination on 05/22/2014. VAERS report filed 04/04/2021, Te